In IL-6+gp130+, IL-6+JAK2+, and IL-6+gp130+JAK2+ cells, the expression of IL-6 was lower in tumor tissues compared with normal tissues (P < 0.05), while the expression of JAK2 and gp130 was comparable (P > 0.05). This evidence concerns the gene JAK2 and neoplasm.